SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARADIGM CORP. ARDM -- Ignore unavailable to you. Want to Upgrade?

To: Edwin Slonim who wrote (10)6/4/1998 8:32:00 PM
From: Marvin Frank  Read Replies (1) | Respond to of 255
 
Dear Edwin, Agree that ARDM stock should have responded to the new Novo deal but it is possible the analysts do not follow the stock that closely. The benefits of insulin administration through other routes than injection is nothing short of spectacular. The recent announcement seemed to indicate that ARDM is ahead of its competitors and we may see the inhalation therapy for insulin released the end of '99. I'm buying more.



To: Edwin Slonim who wrote (10)6/9/1998 4:21:00 PM
From: Gregg Soster  Read Replies (1) | Respond to of 255
 
Dunno, I think LLY may have the mindshare that the "next big thing" is going to come from them.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News